Imugex

Shipping cost plus VAT not included , delivery in 7-14 business days

Categories: Peptides & Proteins / Proteins

Product name			Varicella Zoster Virus, Strain Ellen (VZV)
Catalog No			USB-V2100-18A
Supplier’s Catalog No			V2100-18A
Supplier			US Biologicals
Source antigen			Human Embryo Lung Cell Culture
Reactivity
Cross reactivity
Applications
Molecular weight

Storage			-70°C
Other names
Grade			Purified
Purity			Purified by alkaline treatment and sonnication. Clarified by centrifugation the preparation and further purified on a sucrose density gradient.
Form			Supplied as a liquid in 0.1M glycine buffer, pH 9.5.
Reactivity life			12 months
Note			For reserch purpose only
Purity			Purified by alkaline treatment and sonnication. Clarified by centrifugation the preparation and further purified on a sucrose density gradient.
Description			Varicella Zoster Virus (VZV) is a member of the human herpes virus family which causes two distinct clinical manifestations: childhood chickenpox (Varicella) and shingles (Zoster). Varicella is the outcome of the primary infection with VZV. Whereas, Zoster is the result of VZV reactivation from latently infected sensory ganglia which occurs predominantly in aging and immunosuppressed individuals. Source: Varicella Zoster Virus, strain Ellen, ATCC #VR-586, from human embryo lung cell culture. Inactivation: Inactivated by Beta-propiolactone treatment. Confirmation by attempted growth under original culture conditions. Storage and Stability: Aliquot to avoid repeated freezing and thawing and freeze at -70°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquots are stable for 6 months.